Literature DB >> 16559111

Penicillin-Lysozyme Conversion of Clostridium botulinum Types A and E into Protoplasts and Their Stabilization as L-Form Cultures.

G W Brown1, G King, H Sugiyama.   

Abstract

When logarithmically growing cultures of Clostridium botulinum types A and E are treated with penicillin in a liquid medium containing 8% polyethylene glycol, protoplast-like spherical bodies are formed. The penicillin effect shows a dose-response relationship; the largest yield of converted forms is obtained with 10,000 units/ml, but the treatment leaves many intact bacilli. Lower antibiotic concentrations produce smaller numbers of spherical bodies, but lysis of bacilli results in suspensions that are relatively free of rods. Cells grown under the same conditions and treated with 250 mug of lysozyme/ml do not form spherical bodies. However, a combination of 1,250 to 2,500 units of penicillin and 100 mug of lysozyme/ml yields suspensions which have sphere counts in excess of 1.0 x 10(8)/ml and only a few intact rods. The state of the culture at the time of addition of the antibiotic and enzyme is critical. Suspensions of these protoplasts can be adapted to grow as stable L-form cultures producing the same toxin type as the parent cultures.

Entities:  

Year:  1970        PMID: 16559111      PMCID: PMC248295          DOI: 10.1128/jb.104.3.1325-1331.1970

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  13 in total

1.  SPHEROIDAL AND POLYHEDRAL FORMS OF CLOSTRIDIUM BUTYRICUM INDUCED BY PENICILLIN.

Authors:  T KAWATA; T INOUE
Journal:  J Bacteriol       Date:  1963-07       Impact factor: 3.490

2.  Protoplasts and L-type growth of Escherichia coli.

Authors:  J LEDERBERG; J ST CLAIR
Journal:  J Bacteriol       Date:  1958-02       Impact factor: 3.490

3.  Lysis of gram-negative bacteria by lysozyme.

Authors:  R REPASKE
Journal:  Biochim Biophys Acta       Date:  1956-10

4.  PRODUCTION OF PROTOPLASTS OF ESCHERICHIA COLI BY LYSOZYME TREATMENT.

Authors:  N D Zinder; W F Arndt
Journal:  Proc Natl Acad Sci U S A       Date:  1956-09       Impact factor: 11.205

5.  Autolytic formation of spheroplasts and autolysis of cell walls in Clostridium botulinum type A.

Authors:  T Kawata; K Takumi; S Sato; H Yamashita
Journal:  Jpn J Microbiol       Date:  1968-12

6.  Fine structure of Listeria monocytogenes in relation to protoplast formation.

Authors:  B K Ghosh; R G Murray
Journal:  J Bacteriol       Date:  1967-01       Impact factor: 3.490

7.  Mechanisms of enzymatic bacteriaolysis. Cell walls of bacteri are solubilized by action of either specific carbohydrases or specific peptidases.

Authors:  J L Strominger; J M Ghuysen
Journal:  Science       Date:  1967-04-14       Impact factor: 47.728

8.  Effect of penicillin concentration on "protoplast" production of Streptococcus faecalis.

Authors:  M Y Kubota; J Z Montgomerie; C S Potter; G M Kalmanson; L B Guze
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

9.  Antagonistic effect on Clostridium botulinum type E by organisms resembling it.

Authors:  D A Kautter; S M Harmon; R K Lynt; T Lilly
Journal:  Appl Microbiol       Date:  1966-07

10.  Toxin production in Clostridium botulinum as demonstrated by electron microscopy.

Authors:  J J Duda; J M Slack
Journal:  J Bacteriol       Date:  1969-02       Impact factor: 3.490

View more
  4 in total

1.  Fine structure of protoplasts and L-forms of Clostridium botulinum types A and E.

Authors:  G W Brown; J L Pate; H Sugiyama
Journal:  J Bacteriol       Date:  1971-03       Impact factor: 3.490

Review 2.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

Review 3.  The use of antibiotics for studies of morphogenesis and differentiation in microorganisms.

Authors:  V Betina
Journal:  Folia Microbiol (Praha)       Date:  1980       Impact factor: 2.099

4.  Boticinogeny and actions of the bacteriocin.

Authors:  K L Anastasio; J A Soucheck; H Sugiyama
Journal:  J Bacteriol       Date:  1971-07       Impact factor: 3.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.